Alexander GC, Emerson S, Kesselheim AS. Evaluation of Aducanumab for Alzheimer Disease: Scientific Evidence and Regulatory Review Involving Efficacy, Safety, and Futility. JAMA 2021 Mar 30. pii: 2778191. doi: 10.1001/jama.2021.3854.
PMID: 33783469